Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-57600

Dummer, R; Goldinger, S M; Cozzio, A; French, L E; Karpova, M B (2012). Cutaneous lymphomas: Molecular pathways leading to new drugs. Journal of Investigative Dermatology, 132(3):517-525.

[img]Published Version
PDF - Registered users only
220kB

View at publisher

Abstract

Currently, cutaneous lymphomas represent a paradigm for the heterogeneity and the dynamic variability of neoplastic disorders resulting in the accumulation of clonal lymphocytes in the skin, and thus mirror the complexity of lymphocytic populations. Increasing knowledge and insight in pathobiology offer new opportunities for targeted interventions to selectively hit the tumor populations. mAbs, rexinoids, small kinase inhibitors, or molecules interfering with methylation or histone acetylation contribute to disease control. The rational and well-coordinated application of these tools, together with improved chemotherapeutic options, will hopefully further improve treatment success in the near future.Journal of Investigative Dermatology advance online publication, 8 December 2011; doi:10.1038/jid.2011.370.

Citations

7 citations in Web of Science®
9 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

0 downloads since deposited on 02 Feb 2012
0 downloads since 12 months

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
DDC:610 Medicine & health
Language:English
Date:2012
Deposited On:02 Feb 2012 20:27
Last Modified:12 Dec 2013 19:38
Publisher:Nature Publishing Group
ISSN:0022-202X (P) 1523-1747 (E)
Publisher DOI:10.1038/jid.2011.370
PubMed ID:22158559

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page